Currently, the molecular mechanism underlying the paucity of tumor T‐cell infiltration within tumors and subsequent downregulation of genes associated with the immune response in SCCs with copy number loss of KDM5D is unclear. The gene discussed is KDM5D; the disease is neoplasm.